This document provides an overview of mucoadhesive drug delivery systems (MDDS). It discusses the basics of MDDS, including how they interact with mucus and increase drug residence time. The key mechanisms of mucoadhesion - wetting, swelling, interpenetration and bond formation - are explained. Various mucoadhesive polymer types and factors affecting mucoadhesion are outlined. Different mucoadhesive dosage forms and evaluation methods are also summarized. As an example, the document briefly describes a study that developed Eudragit S100-coated chitosan microspheres to deliver mesalamine for the treatment of ulcerative colitis in a colon-specific manner.